NCT01364168 Prospective Cohort With Incident Stroke
| NCT ID | NCT01364168 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ludwig-Maximilians - University of Munich |
| Condition | Ischemic Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 850 participants |
| Start Date | 2011-02 |
| Primary Completion | 2024-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 850 participants in total. It began in 2011-02 with a primary completion date of 2024-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary aim of the study is to derive and validate risk scores for vascular endpoints (recurrent stroke, myocardial infarction, and other complications of stroke) and for death following an incident stroke. For this purpose patients with an incident stroke will be followed for 36 months with additional assessments at 3, 12, 24 and 36 months.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years * Language: German * First ever acute ischemic stroke that occurred with stroke onset in the last 7 days * Written informed consent by patient prior to study participation * Willingness to participate in follow-up Exclusion Criteria: * Prior stroke (definition according to WHO criteria) * Patients presenting brain tumour or brain metastasis * Participation in an intervention- / AMG-study
Contact & Investigator
Martin Dichgans, Prof.
STUDY CHAIR
Institute for Stroke and Dementia Research, Klinikum der Universität München
Frequently Asked Questions
Who can join the NCT01364168 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Ischemic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01364168 currently recruiting?
Yes, NCT01364168 is actively recruiting participants. Contact the research team at martin.dichgans@med.uni-muenchen.de for enrollment information.
Where is the NCT01364168 trial being conducted?
This trial is being conducted at Berlin, Germany, Munich, Germany.
Who is sponsoring the NCT01364168 clinical trial?
NCT01364168 is sponsored by Ludwig-Maximilians - University of Munich. The principal investigator is Martin Dichgans, Prof. at Institute for Stroke and Dementia Research, Klinikum der Universität München. The trial plans to enroll 850 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.